ID   BIOA_ECOLI              Reviewed;         429 AA.
AC   P12995; Q2MBJ5;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 2.
DT   15-MAR-2017, entry version 155.
DE   RecName: Full=Adenosylmethionine-8-amino-7-oxononanoate aminotransferase;
DE            EC=2.6.1.62;
DE   AltName: Full=7,8-diamino-pelargonic acid aminotransferase;
DE            Short=DAPA AT;
DE            Short=DAPA aminotransferase;
DE   AltName: Full=7,8-diaminononanoate synthase;
DE            Short=DANS;
DE   AltName: Full=Diaminopelargonic acid synthase;
GN   Name=bioA; OrderedLocusNames=b0774, JW0757;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3058702;
RA   Otsuka A.J., Buoncristiani M.R., Howard P.K., Flamm J., Johnson O.,
RA   Yamamoto R., Uchida K., Cook C., Ruppert J., Matsuzaki J.;
RT   "The Escherichia coli biotin biosynthetic enzyme sequences predicted
RT   from the nucleotide sequence of the bio operon.";
RL   J. Biol. Chem. 263:19577-19585(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Pearson B.M., McKee R.A.;
RT   "Genetic material for expression of biotin synthetase enzymes.";
RL   Patent number GB2216530, 11-OCT-1989.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   FUNCTION AS AN AMINOTRANSFERASE, SUBUNIT, SUBSTRATE SPECIFICITY, AND
RP   COFACTOR.
RX   PubMed=1092681;
RA   Stoner G.L., Eisenberg M.A.;
RT   "Purification and properties of 7, 8-diaminopelargonic acid
RT   aminotransferase. An enzyme in the biotin biosynthetic pathway.";
RL   J. Biol. Chem. 250:4029-4036(1975).
RN   [6]
RP   BIOPHYSICOCHEMICAL PROPERTIES, REACTION MECHANISM, AND ENZYME
RP   REGULATION.
RX   PubMed=1092682;
RA   Stoner G.L., Eisenberg M.A.;
RT   "Biosynthesis of 7, 8-diaminopelargonic acid from 7-keto-8-
RT   aminopelargonic acid and S-adenosyl-L-methionine. The kinetics of the
RT   reaction.";
RL   J. Biol. Chem. 250:4037-4043(1975).
RN   [7]
RP   INDUCTION.
RX   PubMed=6456358; DOI=10.1016/0022-2836(81)90043-7;
RA   Barker D.F., Campbell A.M.;
RT   "Genetic and biochemical characterization of the birA gene and its
RT   product: evidence for a direct role of biotin holoenzyme synthetase in
RT   repression of the biotin operon in Escherichia coli.";
RL   J. Mol. Biol. 146:469-492(1981).
RN   [8]
RP   ENZYME REGULATION.
RX   PubMed=16042602; DOI=10.1042/BST0330802;
RA   Mann S., Marquet A., Ploux O.;
RT   "Inhibition of 7,8-diaminopelargonic acid aminotransferase by
RT   amiclenomycin and analogues.";
RL   Biochem. Soc. Trans. 33:802-805(2005).
RN   [9]
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=20693992; DOI=10.1038/nchembio.420;
RA   Lin S., Hanson R.E., Cronan J.E.;
RT   "Biotin synthesis begins by hijacking the fatty acid synthetic
RT   pathway.";
RL   Nat. Chem. Biol. 6:682-688(2010).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND
RP   PYRIDOXAL PHOSPHATE.
RC   STRAIN=B / BL21-DE3;
RX   PubMed=10452893; DOI=10.1006/jmbi.1999.2997;
RA   Kaeck H., Sandmark J., Gibson K., Schneider G., Lindqvist Y.;
RT   "Crystal structure of diaminopelargonic acid synthase: evolutionary
RT   relationships between pyridoxal-5'-phosphate-dependent enzymes.";
RL   J. Mol. Biol. 291:857-876(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   PHOSPHATE AND MUTANTS ALA-391, MUTAGENESIS OF ARG-391, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12379100; DOI=10.1021/bi026339a;
RA   Eliot A.C., Sandmark J., Schneider G., Kirsch J.F.;
RT   "The dual-specific active site of 7,8-diaminopelargonic acid synthase
RT   and the effect of the R391A mutation.";
RL   Biochemistry 41:12582-12589(2002).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS, AND ENZYME REGULATION.
RX   PubMed=12218056; DOI=10.1074/jbc.M207239200;
RA   Sandmark J., Mann S., Marquet A., Schneider G.;
RT   "Structural basis for the inhibition of the biosynthesis of biotin by
RT   the antibiotic amiclenomycin.";
RL   J. Biol. Chem. 277:43352-43358(2002).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF MUTANTS PHE-17; PHE-144;
RP   ASN-147; ALA-253 AND LYS-253 IN COMPLEX WITH PYRIDOXAL PHOSPHATE, AND
RP   MUTAGENESIS OF TYR-17; TYR-144; ASP-147 AND ARG-253.
RX   PubMed=14756557; DOI=10.1021/bi0358059;
RA   Sandmark J., Eliot A.C., Famm K., Schneider G., Kirsch J.F.;
RT   "Conserved and nonconserved residues in the substrate binding site of
RT   7,8-diaminopelargonic acid synthase from Escherichia coli are
RT   essential for catalysis.";
RL   Biochemistry 43:1213-1222(2004).
CC   -!- FUNCTION: Catalyzes the transfer of the alpha-amino group from S-
CC       adenosyl-L-methionine (SAM) to 7-keto-8-aminopelargonic acid
CC       (KAPA) to form 7,8-diaminopelargonic acid (DAPA). It is the only
CC       animotransferase known to utilize SAM as an amino donor.
CC       {ECO:0000269|PubMed:1092681}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + 8-amino-7-
CC       oxononanoate = S-adenosyl-4-methylthio-2-oxobutanoate + 7,8-
CC       diaminononanoate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:1092681};
CC   -!- ENZYME REGULATION: Inhibited by amiclenomycin. S-adenosyl-L-(2-
CC       hydroxy-4-methylthio)butyric acid and adenosine are competitive
CC       inhibitors with SAM and uncompetitive inhibitors with KAPA as
CC       substrates. S-adenosyl-L-ethionine, adenine and 8-keto-7-
CC       aminopelargonic acid are non-competitive inhibitors with both
CC       substrates. {ECO:0000269|PubMed:1092682,
CC       ECO:0000269|PubMed:12218056, ECO:0000269|PubMed:16042602}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.2 uM for KAPA {ECO:0000269|PubMed:1092682,
CC         ECO:0000269|PubMed:12379100};
CC         KM=150 uM for SAM {ECO:0000269|PubMed:1092682,
CC         ECO:0000269|PubMed:12379100};
CC         KM=21 uM for pyridoxamine phosphate (PMP)
CC         {ECO:0000269|PubMed:1092682, ECO:0000269|PubMed:12379100};
CC         KM=32 uM for pyridoxal phosphate (PLP)
CC         {ECO:0000269|PubMed:1092682, ECO:0000269|PubMed:12379100};
CC         KM=1000 uM for 8-keto-7-aminopelargonic acid
CC         {ECO:0000269|PubMed:1092682, ECO:0000269|PubMed:12379100};
CC         Vmax=0.16 umol/min/mg enzyme with KAPA as substrate
CC         {ECO:0000269|PubMed:1092682, ECO:0000269|PubMed:12379100};
CC         Vmax=0.027 umol/min/mg enzyme with 8-keto-7-aminopelargonic acid
CC         as substrate {ECO:0000269|PubMed:1092682,
CC         ECO:0000269|PubMed:12379100};
CC   -!- PATHWAY: Cofactor biosynthesis; biotin biosynthesis; 7,8-
CC       diaminononanoate from 8-amino-7-oxononanoate (SAM route): step
CC       1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10452893,
CC       ECO:0000269|PubMed:1092681, ECO:0000269|PubMed:12218056,
CC       ECO:0000269|PubMed:12379100, ECO:0000269|PubMed:14756557}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- INDUCTION: Repressed by BirA. {ECO:0000269|PubMed:6456358}.
CC   -!- MISCELLANEOUS: Catalysis proceeds by a classical ping-pong bi-bi
CC       reaction mechanism.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. BioA subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04423; AAA23514.1; -; Genomic_DNA.
DR   EMBL; A11524; CAA00964.1; -; Unassigned_DNA.
DR   EMBL; U00096; AAC73861.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76361.1; -; Genomic_DNA.
DR   PIR; F64813; XNECDP.
DR   RefSeq; NP_415295.1; NC_000913.3.
DR   RefSeq; WP_001295303.1; NZ_LN832404.1.
DR   PDB; 1DTY; X-ray; 2.14 A; A/B=1-429.
DR   PDB; 1MGV; X-ray; 2.10 A; A/B=1-429.
DR   PDB; 1MLY; X-ray; 1.81 A; A/B=1-429.
DR   PDB; 1MLZ; X-ray; 2.15 A; A/B=1-429.
DR   PDB; 1QJ3; X-ray; 2.70 A; A/B=1-429.
DR   PDB; 1QJ5; X-ray; 1.80 A; A/B=1-429.
DR   PDB; 1S06; X-ray; 2.20 A; A/B=1-429.
DR   PDB; 1S07; X-ray; 2.42 A; A/B=1-429.
DR   PDB; 1S08; X-ray; 2.10 A; A/B=1-429.
DR   PDB; 1S09; X-ray; 1.83 A; A/B=1-429.
DR   PDB; 1S0A; X-ray; 1.71 A; A/B=1-429.
DR   PDBsum; 1DTY; -.
DR   PDBsum; 1MGV; -.
DR   PDBsum; 1MLY; -.
DR   PDBsum; 1MLZ; -.
DR   PDBsum; 1QJ3; -.
DR   PDBsum; 1QJ5; -.
DR   PDBsum; 1S06; -.
DR   PDBsum; 1S07; -.
DR   PDBsum; 1S08; -.
DR   PDBsum; 1S09; -.
DR   PDBsum; 1S0A; -.
DR   ProteinModelPortal; P12995; -.
DR   SMR; P12995; -.
DR   BioGrid; 4261841; 13.
DR   DIP; DIP-9219N; -.
DR   IntAct; P12995; 5.
DR   MINT; MINT-1275136; -.
DR   STRING; 511145.b0774; -.
DR   DrugBank; DB02274; 7-Keto-8-Aminopelargonic Acid.
DR   DrugBank; DB04083; N'-Pyridoxyl-Lysine-5'-Monophosphate.
DR   PaxDb; P12995; -.
DR   PRIDE; P12995; -.
DR   EnsemblBacteria; AAC73861; AAC73861; b0774.
DR   EnsemblBacteria; BAE76361; BAE76361; BAE76361.
DR   GeneID; 945376; -.
DR   KEGG; ecj:JW0757; -.
DR   KEGG; eco:b0774; -.
DR   PATRIC; 32116749; VBIEscCol129921_0800.
DR   EchoBASE; EB0115; -.
DR   EcoGene; EG10117; bioA.
DR   eggNOG; ENOG4108JPX; Bacteria.
DR   eggNOG; COG0161; LUCA.
DR   HOGENOM; HOG000020209; -.
DR   InParanoid; P12995; -.
DR   KO; K00833; -.
DR   OMA; ANPRINQ; -.
DR   PhylomeDB; P12995; -.
DR   BioCyc; EcoCyc:DAPASYN-MONOMER; -.
DR   BioCyc; MetaCyc:DAPASYN-MONOMER; -.
DR   BRENDA; 2.6.1.62; 2026.
DR   SABIO-RK; P12995; -.
DR   UniPathway; UPA00078; UER00160.
DR   EvolutionaryTrace; P12995; -.
DR   PRO; PR:P12995; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004015; F:adenosylmethionine-8-amino-7-oxononanoate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0009102; P:biotin biosynthetic process; IDA:UniProtKB.
DR   CDD; cd00610; OAT_like; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   HAMAP; MF_00834; BioA; 1.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR005815; BioA.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_major_sub2.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   PIRSF; PIRSF000521; Transaminase_4ab_Lys_Orn; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR00508; bioA; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminotransferase; Biotin biosynthesis;
KW   Complete proteome; Cytoplasm; Pyridoxal phosphate; Reference proteome;
KW   S-adenosyl-L-methionine; Transferase.
FT   CHAIN         1    429       Adenosylmethionine-8-amino-7-oxononanoate
FT                                aminotransferase.
FT                                /FTId=PRO_0000120366.
FT   REGION      112    113       Pyridoxal phosphate binding.
FT   REGION      308    309       Pyridoxal phosphate binding.
FT   BINDING      52     52       Substrate. {ECO:0000269|PubMed:10452893}.
FT   BINDING     144    144       Substrate. {ECO:0000305|PubMed:10452893}.
FT   BINDING     245    245       Pyridoxal phosphate.
FT                                {ECO:0000269|PubMed:10452893,
FT                                ECO:0000269|PubMed:12379100,
FT                                ECO:0000269|PubMed:14756557}.
FT   BINDING     274    274       Substrate. {ECO:0000269|PubMed:10452893}.
FT   BINDING     307    307       Substrate; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:10452893}.
FT   BINDING     391    391       Substrate. {ECO:0000269|PubMed:10452893}.
FT   SITE         17     17       Participates in the substrate recognition
FT                                with KAPA and in a stacking interaction
FT                                with the adenine ring of SAM.
FT                                {ECO:0000305}.
FT   MOD_RES     274    274       N6-(pyridoxal phosphate)lysine.
FT   MUTAGEN      17     17       Y->F: Severely reduces the
FT                                aminotransferase activity.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     144    144       Y->F: Severely reduces the
FT                                aminotransferase activity.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     147    147       D->N: Loss of aminotransferase activity.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     253    253       R->A: Has only a small effect on the rate
FT                                of reaction with DAPA.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     253    253       R->K: Increases aminotransferase activity
FT                                toward SAM.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     253    253       R->M: Loss of aminotransferase activity.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     253    253       R->Q: Increases aminotransferase activity
FT                                toward SAM.
FT                                {ECO:0000269|PubMed:14756557}.
FT   MUTAGEN     391    391       R->A: Reduces aminotransferase activity.
FT                                {ECO:0000269|PubMed:12379100}.
FT   CONFLICT     11     11       R -> P (in Ref. 2; CAA00964).
FT                                {ECO:0000305}.
FT   CONFLICT     99    102       TPQP -> SGRNA (in Ref. 1; AAA23514).
FT                                {ECO:0000305}.
FT   HELIX         3     12       {ECO:0000244|PDB:1S0A}.
FT   STRAND       20     22       {ECO:0000244|PDB:1S0A}.
FT   STRAND       27     34       {ECO:0000244|PDB:1S0A}.
FT   STRAND       36     39       {ECO:0000244|PDB:1S0A}.
FT   STRAND       44     49       {ECO:0000244|PDB:1S0A}.
FT   TURN         50     54       {ECO:0000244|PDB:1S0A}.
FT   HELIX        62     74       {ECO:0000244|PDB:1S0A}.
FT   STRAND       81     84       {ECO:0000244|PDB:1S0A}.
FT   HELIX        86     98       {ECO:0000244|PDB:1S0A}.
FT   STRAND      105    111       {ECO:0000244|PDB:1S0A}.
FT   HELIX       112    130       {ECO:0000244|PDB:1S0A}.
FT   STRAND      136    140       {ECO:0000244|PDB:1S0A}.
FT   HELIX       149    152       {ECO:0000244|PDB:1S0A}.
FT   TURN        157    161       {ECO:0000244|PDB:1S0A}.
FT   HELIX       162    165       {ECO:0000244|PDB:1S0A}.
FT   TURN        166    168       {ECO:0000244|PDB:1S0A}.
FT   STRAND      173    175       {ECO:0000244|PDB:1S0A}.
FT   STRAND      180    184       {ECO:0000244|PDB:1DTY}.
FT   HELIX       188    191       {ECO:0000244|PDB:1S0A}.
FT   HELIX       192    201       {ECO:0000244|PDB:1S0A}.
FT   TURN        202    204       {ECO:0000244|PDB:1S0A}.
FT   STRAND      205    210       {ECO:0000244|PDB:1S0A}.
FT   STRAND      212    215       {ECO:0000244|PDB:1S0A}.
FT   TURN        217    219       {ECO:0000244|PDB:1S0A}.
FT   STRAND      221    223       {ECO:0000244|PDB:1S0A}.
FT   HELIX       226    238       {ECO:0000244|PDB:1S0A}.
FT   STRAND      241    245       {ECO:0000244|PDB:1S0A}.
FT   TURN        247    254       {ECO:0000244|PDB:1S0A}.
FT   STRAND      255    258       {ECO:0000244|PDB:1S0A}.
FT   HELIX       259    263       {ECO:0000244|PDB:1S0A}.
FT   STRAND      268    272       {ECO:0000244|PDB:1S0A}.
FT   HELIX       274    277       {ECO:0000244|PDB:1S0A}.
FT   STRAND      279    281       {ECO:0000244|PDB:1S0A}.
FT   STRAND      284    288       {ECO:0000244|PDB:1S0A}.
FT   HELIX       290    297       {ECO:0000244|PDB:1S0A}.
FT   STRAND      299    303       {ECO:0000244|PDB:1MGV}.
FT   TURN        309    312       {ECO:0000244|PDB:1S0A}.
FT   HELIX       314    328       {ECO:0000244|PDB:1S0A}.
FT   HELIX       332    347       {ECO:0000244|PDB:1S0A}.
FT   HELIX       348    352       {ECO:0000244|PDB:1S0A}.
FT   STRAND      356    362       {ECO:0000244|PDB:1S0A}.
FT   STRAND      365    372       {ECO:0000244|PDB:1S0A}.
FT   HELIX       376    385       {ECO:0000244|PDB:1S0A}.
FT   STRAND      396    399       {ECO:0000244|PDB:1S0A}.
FT   HELIX       407    420       {ECO:0000244|PDB:1S0A}.
FT   HELIX       424    426       {ECO:0000244|PDB:1S0A}.
SQ   SEQUENCE   429 AA;  47336 MW;  84D2D1AE3A1280FF CRC64;
     MTTDDLAFDQ RHIWHPYTSM TSPLPVYPVV SAEGCELILS DGRRLVDGMS SWWAAIHGYN
     HPQLNAAMKS QIDAMSHVMF GGITHAPAIE LCRKLVAMTP QPLECVFLAD SGSVAVEVAM
     KMALQYWQAK GEARQRFLTF RNGYHGDTFG AMSVCDPDNS MHSLWKGYLP ENLFAPAPQS
     RMDGEWDERD MVGFARLMAA HRHEIAAVII EPIVQGAGGM RMYHPEWLKR IRKICDREGI
     LLIADEIATG FGRTGKLFAC EHAEIAPDIL CLGKALTGGT MTLSATLTTR EVAETISNGE
     AGCFMHGPTF MGNPLACAAA NASLAILESG DWQQQVADIE VQLREQLAPA RDAEMVADVR
     VLGAIGVVET THPVNMAALQ KFFVEQGVWI RPFGKLIYLM PPYIILPQQL QRLTAAVNRA
     VQDETFFCQ
//
